Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
Randomized Controlled Trial
[키워드] 1:1
95% CI
Abstract
Adaptive platform trial
adverse event
age
Analysis
Arm
assigned
average
Bayesian
Bayesian credible interval
BCI
Brazil
Care
clinical trial
composite endpoint
COVID-19
COVID-19 emergency
death
defined
diagnosed
early treatment
Effect
Efficacy
eligible patient
events
Evidence
female
finding
foundation
groups
hospital
hospitalisation
hospitalisations
indicate
initiated
intention to treat
intention-to-treat analysis
Intervention
material
modified intention-to-treat
no significant difference
Odds ratio
Outpatient
participant
Patient
per-protocol analysis
per-protocol population
Placebo
placebo-controlled
platform
positive
potential participant
Primary outcome
Probability
progression
proportion
protocol
randomisation
randomised
Randomly
receiving
recent
reduced
Registered
reported
risk
risk factor
SARS-CoV-2
screened
severe disease
symptomatic
symptomatic patient
the placebo group
therapeutic
threshold
transfer
transferred
translation
Treatment
treatment allocation
treatment group
Trial
with COVID-19
[DOI] 10.1016/S2214-109X(21)00448-4 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1016/S2214-109X(21)00448-4 PMC 바로가기 [Article Type] Randomized Controlled Trial